Ernexa Therapeutics Inc. Tax Withholding Paid on Stock Awards
Ernexa Therapeutics Inc. (ERNA) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2024-03-14
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-12-31 was $0.00.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-09-30 was $0.00.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-12-31 was $0.00.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-09-30 was $0.00.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $5.00K.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Ernexa Therapeutics Inc. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $46.00K, a 24.32% increase from fiscal 2019.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $5.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | $0.00 10-K · filed 2023-03-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $19.00K derived: sum of 2 quarters · filed 2021-03-11 | $26.00K derived: sum of 3 quarters · filed 2021-03-11 | $46.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $16.00K derived: sum of 2 quarters · filed 2020-11-13 | $36.00K 10-Q · filed 2020-11-13 | $44.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $27.00K 10-Q · filed 2020-08-07 | $35.00K derived: sum of 3 quarters · filed 2021-03-11 | $51.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-03-31 | $20.00K 10-Q · filed 2020-05-20 | $28.00K derived: sum of 2 quarters · filed 2021-03-11 | $44.00K derived: sum of 3 quarters · filed 2021-03-11 | $52.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $24.00K derived: sum of 2 quarters · filed 2021-03-11 | $32.00K derived: sum of 3 quarters · filed 2021-03-11 | $37.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $24.00K derived: sum of 2 quarters · filed 2020-11-13 | $29.00K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $13.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-20 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $6.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $6.00K derived: sum of 3 quarters · filed 2016-03-15 | $18.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $6.00K derived: sum of 2 quarters · filed 2016-03-15 | $18.00K derived: sum of 3 quarters · filed 2016-03-15 | $33.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $18.00K derived: sum of 2 quarters · filed 2015-11-09 | $33.00K 10-Q · filed 2015-11-09 | $39.00K derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $27.00K 10-Q · filed 2015-08-10 | $33.00K derived: sum of 3 quarters · filed 2015-08-10 | $36.00K derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $15.00K 10-Q · filed 2015-05-08 | $21.00K derived: sum of 2 quarters · filed 2015-05-08 | $24.00K derived: sum of 3 quarters · filed 2015-05-08 | |
| 2013-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $9.00K derived: sum of 2 quarters · filed 2015-03-27 | $16.00K 10-K · filed 2015-03-27 | |
| 2013-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $10.00K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $7.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |